GSK

(GSK)
Sector: Pharmaceuticals & Biotechnology
1,394.00p
-15.50p -1.10
Last updated: 16:55:00

Company News Headlines

Date Time Headline Source
03/07/2025 07:00 Transaction in Own Shares RNS
02/07/2025 07:00 Transaction in Own Shares RNS
01/07/2025 15:00 Total Voting Rights RNS
01/07/2025 07:00 Transaction in Own Shares RNS
30/06/2025 07:00 Transaction in Own Shares RNS
27/06/2025 07:00 Transaction in Own Shares RNS
26/06/2025 07:00 Transaction in Own Shares RNS
25/06/2025 07:00 Transaction in Own Shares RNS
24/06/2025 15:30 Director/PDMR Shareholding RNS
24/06/2025 15:00 Director Declaration RNS
24/06/2025 07:00 Transaction in Own Shares RNS
23/06/2025 17:50 Replacement - Director/PDMR Shareholding RNS
23/06/2025 15:30 Director/PDMR Shareholding RNS
23/06/2025 08:30 Replacement RNS: Linerixibat file accepted by EMA RNS
23/06/2025 08:18 GSK Submits Arexvy for adults 18+ with EMA RNS
23/06/2025 07:00 Transaction in Own Shares RNS
20/06/2025 07:00 Arexvy filed in Japan for 18-49 at increased risk RNS
20/06/2025 07:00 Transaction in Own Shares RNS
19/06/2025 07:00 Transaction in Own Shares RNS
18/06/2025 07:00 Transaction in Own Shares RNS
17/06/2025 07:00 Transaction in Own Shares RNS
16/06/2025 07:00 Transaction in Own Shares RNS
13/06/2025 15:30 Director/PDMR Shareholding RNS
13/06/2025 07:00 Transaction in Own Shares RNS
13/06/2025 07:00 GSK submits Arexvy for adults 18+ with EMA RNS
12/06/2025 11:00 Director/PDMR Shareholding PR Newswire
12/06/2025 07:00 Transaction in Own Shares RNS
11/06/2025 15:30 Director/PDMR Shareholding RNS
11/06/2025 07:00 Transaction in Own Shares RNS
10/06/2025 07:00 Transaction in Own Shares RNS
09/06/2025 07:00 Transaction in Own Shares RNS
06/06/2025 07:00 Transaction in Own Shares RNS
05/06/2025 07:00 Transaction in Own Shares RNS
04/06/2025 07:00 GSK - second tranche of share buyback programme RNS
04/06/2025 07:00 Transaction in Own Shares RNS
03/06/2025 07:00 Transaction in Own Shares RNS
02/06/2025 15:30 Director/PDMR Shareholding RNS
02/06/2025 15:00 Total Voting Rights RNS
02/06/2025 07:00 Linerixibat file accepted for review by US FDA RNS
02/06/2025 07:00 Transaction in Own Shares RNS
30/05/2025 07:00 Transaction in Own Shares RNS
29/05/2025 07:00 Transaction in Own Shares RNS
28/05/2025 12:00 GSK stops Phase 3 trial on cUTIs for efficacy RNS
28/05/2025 07:00 Transaction in Own Shares RNS
27/05/2025 07:00 Transaction in Own Shares RNS
23/05/2025 12:16 positive CHMP opinion on Blenrep in EU RNS
23/05/2025 07:00 FDA approves Nucala COPD indication RNS
23/05/2025 07:00 Transaction in Own Shares RNS
22/05/2025 07:00 Transaction in Own Shares RNS
21/05/2025 07:00 Transaction in Own Shares RNS